A Study of Distal Jejunal-release Dextrose in Obese Participants
A phase 2 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 150 participants.
Also called NCT05385978
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 150 participants
- Sponsor
- Aphaia Pharma US LLC
- Registry
-
NCT05385978
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Georgia, Germany, Puerto Rico
- Registry status
- Unknown status
Technical summary
Registry record NCT05385978. Randomized; quadruple masking; primary purpose treatment. Start 2022-11-01 (actual); primary completion 2024-11-11 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Study of Distal Jejunal-release Dextrose in Obese Participants
- Condition
- Obese
- Intervention (Drug)
- APHD-012
- Intervention (Drug)
- APHD-012P
- Lead sponsor
- Aphaia Pharma US LLC
Record details
- Record id
cardio:ct-nct05385978- Content hash
567558c8ebf132fe90be2c94bce3477e20a14a57aa922d90ac1aa6a496173f93